An Update to the Overview of Reviews: Risks of and From SARS-COV-2 Infection and COVID-19 in People With Diabetes
Diabetes Care
.
2023 Dec 1;46(12):e215-e216.
doi: 10.2337/dc23-1365.
Authors
Jamie Hartmann-Boyce
1
2
,
Karen Rees
3
,
Igho Onakpoya
4
,
Afolarin Otunla
5
,
Elizabeth Morris
1
,
Jessica Morgan
5
,
Patrick Highton
6
,
Jana Suklan
7
,
Ffion Curtis
8
,
Clare Goyder
1
,
Lauren O'Mahoney
6
,
Olivia James
5
,
Nayanika Sreejith
5
,
Samuel Seidu
6
,
Kamlesh Khunti
6
Affiliations
1
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, U.K.
2
University of Massachusetts Amherst, Amherst, MA.
3
Freelance systematic reviewer, Warwickshire, U.K.
4
Department of Continuing Education, University of Oxford, Oxford, U.K.
5
Medical Sciences Division, University of Oxford, Oxford, U.K.
6
Diabetes Research Centre, University of Leicester, Leicester, U.K.
7
National Institute for Health Research Newcastle In Vitro Diagnostics Co-operative, Newcastle University, Newcastle upon Tyne, U.K.
8
Liverpool Reviews & Implementation Group (LRiG), University of Liverpool, Liverpool, U.K.
PMID:
37856358
DOI:
10.2337/dc23-1365
No abstract available
Publication types
Review
MeSH terms
COVID-19*
Diabetes Mellitus* / epidemiology
Humans
SARS-CoV-2
Grants and funding
WT_/Wellcome Trust/United Kingdom